Uptravi 1800 MCG Injection

RxCUI: 2565275
RxNorm name: Uptravi 1800 MCG Injection
Display name: Uptravi 1800 MCG Injection
Full name: Uptravi 1800 MCG Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:13

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
UPTRAVI	SELEXIPAG	Actelion Pharmaceuticals US, Inc.	a7a23b87-f892-4e2c-8e2e-ebf841220f90	2026-05-28	Warnings, Adverse reactions	Exact identifier rxcui: 2565275

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
a7a23b87-f892-4e2c-8e2e-ebf841220f90	Uptravi 1800 MCG Injection [PSN] · selexipag 1.8 MG Injection [Uptravi] [SBD] · Uptravi 1.8 MG Injection [SY] · Uptravi 1800 MCG Injection [SY]	4	26	These highlights do not include all the information needed to use UPTRAVI safely and effectively. See full prescribing information for UPTRAVI. UPTRAVI ® (selexipag) tablets, for oral use UPTRAVI ® (selexipag) for injection, for intravenous use Initial U.S. Approval: 2015	20260528